← Eichor
Condition: Prostate Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prostate Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Phase 2 · 1 location(s) · Ivan de Kouchkovsky, MD · NCT06384222The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Phase 2 · 4 location(s) · Yale University · NCT06111781Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06995053Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
NA · 1 location(s) · University of Rochester · NCT07071207Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05956639A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Phase 1/Phase 2 · 18 location(s) · Pathos AI, Inc. · NCT06785636Study of AZD0754 in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · 15 location(s) · AstraZeneca · NCT06267729A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Phase 1/Phase 2 · 12 location(s) · Memorial Sloan Kettering Cancer Center · NCT06457919Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT06828263Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05443412Intestinal Akkermansia Muciniphila in Prostate Cancer
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06242509Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of P
Phase 2/Phase 3 · 1 location(s) · baotai Liang · NCT06861192RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT06856694Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
NA · 1 location(s) · University of Eastern Finland · NCT07369570STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Angela Y. Jia, MD PhD · NCT06574880A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or M
Phase 1/Phase 2 · 4 location(s) · Genentech, Inc. · NCT07567846A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patien
Phase 2/Phase 3 · 2 location(s) · Shanghai Jiao Tong University School of Medicine · NCT03258320SRT Versus SRT+ADT in Prostate Cancer
Phase 3 · 1 location(s) · Marco Lorenzo Bonu · NCT05019846Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Phase 1/Phase 2 · 2 location(s) · Virginia Commonwealth University · NCT06237179A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT06052683Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Local
NA · 1 location(s) · University of Zurich · NCT07042256Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Phase 2 · 18 location(s) · VA Office of Research and Development · NCT04038502An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06330805Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT05919329High Intensity Focused Ultrasound in Prostate Cancer
Phase 2 · 1 location(s) · University of Florida · NCT06402357CART-PSMA Cells for Advanced Prostate Cancer
Phase 1 · 1 location(s) · Nova Therapeutics LLC · NCT05656573Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
NA · 3 location(s) · Royal Marsden NHS Foundation Trust · NCT06638541
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.